🇺🇸 FDA
Pipeline program

Neulasta 6 mg solution for injection

CDF 711

Phase 2 small_molecule active

Quick answer

Neulasta 6 mg solution for injection for Severe chronic neutropenia (SCN) is a Phase 2 program (small_molecule) at Istituto Gentili S.r.l. with 1 ClinicalTrials.gov record(s).

Program details

Company
Istituto Gentili S.r.l.
Indication
Severe chronic neutropenia (SCN)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials